The variant of the SARS-CoV-2 virus known as B.1.1.7 is still susceptible to antibodies induced after COVID-19 infection or immunization with a currently available vaccine, according to Emory University scientists. The increasingly prevalent B.1.1.7 variant was first identified in the United Kingdom, and was detected in the United States in December 2020. It is thought […]
A team of researchers based in Stockholm, Sweden, has demonstrated that individuals exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have antibodies for the disease up to nine months after acquiring the disease, even if they displayed only mild symptoms. Study: Persisting Salivary IgG against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary […]
As new variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to emerge, fueling the continued spread of the coronavirus disease 2019 (COVID-19) pandemic, a new study offers encouragement. Released as a preprint on the bioRxiv* server, the study reports the protection offered by antibodies elicited by natural infection against the newer variants […]
Researchers in the United States say the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant – P.1 – that has recently emerged in Brazil shows a worrying level of resistance to neutralization by antibodies. The SARS-CoV-2 virus is the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic that poses an ongoing threat to mankind […]
Ask Eric Weaver about pandemics, and he's quick to remind you of a fact that illustrates the fleeting nature of human memory and the proximal nature of human attention: The first pandemic of the 21st century struck not in 2019, but 2009. That's when the H1N1/09 swine flu emerged, eventually infecting upwards of 1.4 billion […]
New York has the first case of a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant called B.1.526, picked up by genomic surveillance research from Columbia University. The findings come after reports of other variants have been reported worldwide — B.1.1.7 in the United Kingdom, B.1.351 in South Africa, and P.1/P.2 in Brazil. If […]
In a major advance in the treatment of multiple myeloma, a CAR T-cell therapy has generated deep, sustained remissions in patients who had relapsed from several previous therapies, an international clinical trial has found. In a study posted online today by the New England Journal of Medicine, trial leaders report that almost 75% of the […]
Researchers in the United States and Canada have conducted a study showing that just a single dose of either the Pfizer-BioNTech or Moderna vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is likely to protect against emerging variants. The SARS-CoV-2 virus is the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic that continues […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MABTHERA IV NHL AND CLL 160310 For the treatment of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukaemia pronounced (mab-thir-ra) contains the active ingredient rituximab (rch) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about MabThera intravenous infusion.It […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VAQTA® Hepatitis A vaccine, Inactivated (hepatitis A virus, inactivated) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about VAQTA.It does not contain all the available information. It does not take the place of talking to your […]
